Life ScienceCompany
Saol Therapeutics - Baclofen Franchise Ownership
Who owns Saol Therapeutics - Baclofen Franchise?
Saol Therapeutics - Baclofen Franchise is owned by Amneal Pharmaceuticals. It was acquired on January 5, 2022.
Saol Therapeutics - Baclofen Franchise Business Overview
Where is Saol Therapeutics - Baclofen Franchise headquartered?
Saol Therapeutics - Baclofen Franchise is headquartered in Roswell, Georgia.
What sector is Saol Therapeutics - Baclofen Franchise in?
Saol Therapeutics - Baclofen Franchise is a life science company.
Life Science M&A Summary in 2022
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.
Join Mergr to view all 294 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 257 by strategics.